Liraglutide for management of adolescent obesity

(2020) Liraglutide for management of adolescent obesity. Nature Reviews Endocrinology. pp. 405-406. ISSN 1759-5029

Full text not available from this repository.

Abstract

Available interventions for adolescents with obesity are based on behavioural therapy and lifestyle modification. A new randomized, controlled trial provides evidence of efficacy of a pharmacological therapy, liraglutide, for weight control in adolescent obesity. The indications for more widespread use of this medication in clinical practice are under discussion.

Item Type: Article
Keywords: adolescent obesity
Subjects: WD Disorders of Systemic, Metabolic or Environmental Origin, etc.
WS Pediatrics
Divisions: Research Institute for Primordial Prevention of Non-communicable Disease > Child Growth and Development Research Center
Page Range: pp. 405-406
Journal or Publication Title: Nature Reviews Endocrinology
Journal Index: ISI
Volume: 16
Number: 8
Identification Number: https://doi.org/10.1038/s41574-020-0371-7
ISSN: 1759-5029
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/12928

Actions (login required)

View Item View Item